Guest guest Posted September 3, 2010 Report Share Posted September 3, 2010 A Step Closer To Development Of Drug To Prevent Deadly Immune Response MedicalNewsToday.com Article Date: 30 Aug 2010 - 1:00 PDT Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology. The molecule, a modified peptide, was extracted from the relatively huge protein shell of a common virus that is a frequent cause of childhood diarrhea, according to the research conducted by a team at Eastern Virginia Medical School and Children's Hospital of The King's Daughters. ********************************************* Read the full article here: http://www.medicalnewstoday.com/articles/199217.php Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.